Biotechnology · Healthcare
Board Member
2024-03-05–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Hepion Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get HEPA alertsMichael Purcell is recorded as Board Member at Hepion Pharmaceuticals, Inc. (HEPA) since March 5, 2024. Hepion Pharmaceuticals, Inc. reported in an 8-K filed March 6, 2024 that Michael Purcell was appointed Chair of the Audit Committee, effective March 5, 2024. Hepion Pharmaceuticals, Inc. reported in an 8-K filed March 6, 2024 that Michael Purcell was appointed director, effective March 5, 2024. Hepion Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Hepion Pharmaceuticals, Inc. includes Dr. Kaouthar Lbiati (CEO), Gary Stetz (CEO, CFO and Board Member), John Cavan (CEO and CFO) and 7 others.
“In addition, Mr. Purcell was appointed as Chair of the Audit Committee and a member of the Compensation Committee and Corporate Governance/Nominations Committee.”
“On March 5, 2024, the Board of Directors of Hepion Pharmaceuticals, Inc. (the "Company") appointed Michael Purcell as a director of the Company.”
2024-03-05–present
2024-03-05–present
Biotechnology · Healthcare
Board Member
2024-03-05–present